Related Experiment Video
Updated: Aug 13, 2026
11:56
In Vitro Bioluminescence Assay to Characterize Circadian Rhythm in Mammary Epithelial Cells
Published on: September 28, 2017
Circadian cholinergic rhythms: implications for cholinesterase inhibitor therapy
1Synaptec, Cold Spring Harbor, NY, USA. bonniemdavis@aol.com
Dementia and Geriatric Cognitive Disorders
|January 5, 2006
Summary
Current Alzheimer's disease (AD) therapies may disrupt natural body rhythms. Optimizing cholinergic treatments requires considering drug duration and timing to align with daily biological cycles.
Area of Science:
- Neuroscience
- Pharmacology
- Chronobiology
Background:
- Current Alzheimer's disease (AD) treatments focus on the cholinergic system.
- These therapies are generally well-tolerated and convenient for daily administration.
- However, their efficacy may be impacted by interactions with endogenous circadian rhythms.
Purpose of the Study:
- To evaluate the potential conflict between current cholinergic drug administration and natural circadian rhythms in AD.
- To explore how drug duration and timing affect therapeutic outcomes.
- To propose considerations for optimizing cholinergic therapies for Alzheimer's disease.
Main Methods:
- Analysis of existing data on cholinergic system physiology and circadian rhythms.
- Review of pharmacokinetic and pharmacodynamic properties of current AD drugs.
- Assessment of potential impacts on sleep and memory consolidation.
Main Results:
- Longer-acting drugs may oppose the diurnal pattern of cholinergic activity.
- This can potentially disrupt sleep and memory processes.
- Tolerance development and counterregulatory increases in acetylcholinesterase (AChE) can reduce drug effectiveness.
Conclusions:
- Drug duration and timing are critical factors for effective cholinergic therapy in AD.
- Aligning administration with natural cholinergic rhythms may improve treatment outcomes.
- Further research is needed to optimize dosing strategies for Alzheimer's therapeutics.
Related Concept Videos
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
01:31Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
01:22Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...